BCL2 and colorectal cancer: We also established that the Bax/Bcl-2 ratio was lower in differentiated than in non-differentiated cells, confirming the same findings in normal and tumor tissue and suggesting that this ratio could be used as a prognostic or predictive marker for the fate of colorectal cancer cells upon treatment [32].